Mathini Ilancheran updates us on how delayed U.S. tariffs on generic drug imports could reshape supply, sourcing, and trial planning.
- June 2026 — CDMO Opportunities And Threats Report
- The Decision Rights Matrix: Making Sponsor-CDMO Governance Enforceable
- Defining Quality In A Sponsor-Owned QTPP Before The CDMO Even Starts
- ImvivaBio's Trial For Off-The-Shelf CAR-T Strategy For Aggressive Malignancies
- Reshoring Pressure Meets Manufacturing Reality
- CDMO Live Europe 2026: Partnerships For An Uncertain World
- Resilience, Risk, And Relationships: CDMO Live Europe 2026 Report
- Demonstrating Non-Inferiority Of BFPCs Vs. Traditional Air Monitoring
CELL & GENE ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS
-
![GettyImages-2190227882-male-scientist-lab]( "Automated Enrichment Of Human CD34+ Cells")
Automated Enrichment Of Human CD34+ CellsExplore an automated approach to CD34+ cell enrichment that combines scalable processing and high-purity cell recovery, offering insight into performance metrics and practical considerations.
-
![GettyImages-2181934436-laboratory-analysis-scientists-technology-computer]( "Quantifying Lentiviral Physical Titer Using The QIAcuity dPCR System")
Quantifying Lentiviral Physical Titer Using The QIAcuity dPCR SystemStreamline lentiviral vector analytics with our direct RT-dPCR method. Achieve precise, reproducible results to accelerate safe, effective gene therapies with enhanced quality control.
-
![T-Cells Work to Fight Cancer, Immunotherapy, CAR T-cell therapy-GettyImages-1317697233]( "Revolutionizing Lentiviral Vector Manufacturing For In Vivo, Ex Vivo CAR-T Therapies")
Revolutionizing Lentiviral Vector Manufacturing For In Vivo, Ex Vivo CAR-T TherapiesDiscover how scalable, cost-effective, and high-quality lentiviral vector manufacturing can accelerate both ex vivo and emerging in vivo CAR-T therapies.
-
![GettyImages-1403976499-scientist-pharma-manufacturing-vaccine]( "Non Animal Origin Squalene For High-Risk Applications")
Non Animal Origin Squalene For High-Risk ApplicationsExplore an ethical and sustainable alternative to shark-derived squalene that is backed by robust data to deliver identical performance in vaccine formulations without environmental compromise.
-
![450_300-microalgae_cultivation]( "Phototrophic Cultivation Of <em>Chlorella vulgaris</em> In Microbioreactors")
Phototrophic Cultivation Of Chlorella vulgaris In MicrobioreactorsUnlock efficient microalgae cultivation with precise lighting and real-time insights. Explore ways to boost biomass, optimize growth, and accelerate sustainable bioenergy and bioproduct innovation.
-
![GettyImages-1441662840-lab-team-communication-collaboration]( "Integrated Services For Cell Line Preparation And Storage")
Integrated Services For Cell Line Preparation And StorageExplore a comprehensive suite of services for the manufacture, characterization, and storage of cell banks as well as the advantages of working with an experienced partner.
-
![genetic research, biotechnology, molecular biology, innovation, healthcare solutions-GettyImages-2234236209]( "How Automated NGS Solutions Advance Rare Disease Research")
How Automated NGS Solutions Advance Rare Disease ResearchSee how a unified NGS workflow is helping a major pediatric genetics lab boost efficiency, manage growing sample volumes, and accelerate insights into rare diseases through streamlined automation.
-
![GettyImages-2184219690-chimeric-antibody-3d-render]( "How To Design And Evaluate Bispecific Antibodies (BsAbs)?")
How To Design And Evaluate Bispecific Antibodies (BsAbs)?Bispecific antibodies combine two antigen-binding sites to enhance efficacy and safety. Their design requires structural strategy, MOA-based evaluation, and rigorous screening for optimal therapeutic performance.
-
![GettyImages-1259302414 lab, research, culture]( "A Novel Cell-Based Assay For Ubiquitin Drug Discovery")
A Novel Cell-Based Assay For Ubiquitin Drug DiscoveryLearn about a novel cell-based assay that can advance ubiquitin ligase drug discovery. This high-throughput method simplifies assay development, saving time and resources.
-
![Thermo Fisher - Peptones]( "The Value Of Peptones For Enhancing Biopharmaceutical Productivity")
The Value Of Peptones For Enhancing Biopharmaceutical ProductivityPeptones, versatile media additives derived from various sources, offer numerous benefits for biopharmaceutical production.
NEWSLETTER ARCHIVE
- 08.08.26 -- Cell & Gene Newsletter - Best Of July
- 08.07.26 -- New Podcast Episodes: BoB@BIO, In Vivo Gene Editing, Multispecific Manufacturability, and More
- 08.07.26 -- Inside ImvivaBio's Trial For Off-The-Shelf CAR-T Strategy For Aggressive T-Cell Malignancies
- 08.06.26 -- The CDMO Perspective On Breaking Down Development Silos In Vivo CGT
- 08.05.26 -- Advancing Precision In Clinical Trial Design
- Solving Vector Yield Challenges Starts Long Before Manufacturing
- Full FDA Approval For TECELRA Marks More Than A Regulatory Win For Solid Tumors
- FDA Approval Of TREGZI Signals A New Era For Precision Engineered Cell Therapy
- How CGT Developers Should Think About Manufacturing Models, Hybrid Strategies, And Scale
- In Vivo Gene Editing Is Moving From Promise To Proof
CELL AND GENE CONTENT COLLECTIONS
While there are opportunities to scale, there are also manufacturing gaps, capacity issues, and production timelines that require improvement to do so. And then, of course, there’s cost. Because scale up and scale out are significant to everyone in the sector, we’ve curated insightful editorial that addresses the most important aspects of scalability.
More Content Collections
